Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
Type:
Grant
Filed:
February 25, 2002
Date of Patent:
September 6, 2005
Assignee:
Genetics Institute, LLC
Inventors:
Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan